世界のテノホビル/アラフェナミド複合薬市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21MY17334)
◆英語タイトル:Global Tenofovir/Alafenamide Compound Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21MY17334
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年5月
◆ページ数:104
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、テノホビル/アラフェナミド複合薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。テノホビル/アラフェナミド複合薬の種類別市場規模(ボトル包装、フィルムコーティング包装)、用途別市場規模(慢性肝炎(HBV)患者(成人)、慢性肝炎(HBV)患者(12歳以上子供))、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Gilead Sciences、Cipla、Mylan Pharmaceuticals、Natco Pharma、Sun Pharmaceutical Industries、Beacon Pharmaceuticals、Julphar Bangladesh
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ボトル包装、フィルムコーティング包装
・用途別分析2016年-2026年:慢性肝炎(HBV)患者(成人)、慢性肝炎(HBV)患者(12歳以上子供)
・テノホビル/アラフェナミド複合薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・テノホビル/アラフェナミド複合薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・テノホビル/アラフェナミド複合薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・テノホビル/アラフェナミド複合薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・テノホビル/アラフェナミド複合薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Tenofovir/Alafenamide Compound Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Tenofovir/Alafenamide Compound Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Tenofovir/Alafenamide Compound Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Tenofovir/Alafenamide Compound Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Bottled Packaging
Film Coated Packaging

Market segment by Application can be divided into
Chronic Hepatitis (HBV) in Adults
Chronic Hepatitis (HBV) in Children over 12 Years Old

The key market players for global Tenofovir/Alafenamide Compound Drugs market are listed below:
Gilead Sciences
Cipla
Mylan Pharmaceuticals
Natco Pharma
Sun Pharmaceutical Industries
Beacon Pharmaceuticals
Julphar Bangladesh

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Tenofovir/Alafenamide Compound Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tenofovir/Alafenamide Compound Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Bottled Packaging
1.2.3 Film Coated Packaging
1.3 Market Analysis by Application
1.3.1 Overview: Global Tenofovir/Alafenamide Compound Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Chronic Hepatitis (HBV) in Adults
1.3.3 Chronic Hepatitis (HBV) in Children over 12 Years Old
1.4 Global Tenofovir/Alafenamide Compound Drugs Market Size & Forecast
1.4.1 Global Tenofovir/Alafenamide Compound Drugs Sales in Value (2016-2026))
1.4.2 Global Tenofovir/Alafenamide Compound Drugs Sales in Volume (2016-2026)
1.4.3 Global Tenofovir/Alafenamide Compound Drugs Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Tenofovir/Alafenamide Compound Drugs Production Capacity Analysis
1.5.1 Global Tenofovir/Alafenamide Compound Drugs Total Production Capacity (2016-2026)
1.5.2 Global Tenofovir/Alafenamide Compound Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tenofovir/Alafenamide Compound Drugs Market Drivers
1.6.2 Tenofovir/Alafenamide Compound Drugs Market Restraints
1.6.3 Tenofovir/Alafenamide Compound Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Tenofovir/Alafenamide Compound Drugs Product and Services
2.1.4 Gilead Sciences Tenofovir/Alafenamide Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Cipla
2.2.1 Cipla Details
2.2.2 Cipla Major Business
2.2.3 Cipla Tenofovir/Alafenamide Compound Drugs Product and Services
2.2.4 Cipla Tenofovir/Alafenamide Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Mylan Pharmaceuticals
2.3.1 Mylan Pharmaceuticals Details
2.3.2 Mylan Pharmaceuticals Major Business
2.3.3 Mylan Pharmaceuticals Tenofovir/Alafenamide Compound Drugs Product and Services
2.3.4 Mylan Pharmaceuticals Tenofovir/Alafenamide Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Natco Pharma
2.4.1 Natco Pharma Details
2.4.2 Natco Pharma Major Business
2.4.3 Natco Pharma Tenofovir/Alafenamide Compound Drugs Product and Services
2.4.4 Natco Pharma Tenofovir/Alafenamide Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sun Pharmaceutical Industries
2.5.1 Sun Pharmaceutical Industries Details
2.5.2 Sun Pharmaceutical Industries Major Business
2.5.3 Sun Pharmaceutical Industries Tenofovir/Alafenamide Compound Drugs Product and Services
2.5.4 Sun Pharmaceutical Industries Tenofovir/Alafenamide Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Beacon Pharmaceuticals
2.6.1 Beacon Pharmaceuticals Details
2.6.2 Beacon Pharmaceuticals Major Business
2.6.3 Beacon Pharmaceuticals Tenofovir/Alafenamide Compound Drugs Product and Services
2.6.4 Beacon Pharmaceuticals Tenofovir/Alafenamide Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Julphar Bangladesh
2.7.1 Julphar Bangladesh Details
2.7.2 Julphar Bangladesh Major Business
2.7.3 Julphar Bangladesh Tenofovir/Alafenamide Compound Drugs Product and Services
2.7.4 Julphar Bangladesh Tenofovir/Alafenamide Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Tenofovir/Alafenamide Compound Drugs Sales by Manufacturer
3.1 Global Tenofovir/Alafenamide Compound Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Tenofovir/Alafenamide Compound Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Tenofovir/Alafenamide Compound Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Tenofovir/Alafenamide Compound Drugs Manufacturer Market Share
3.4.2 Top 6 Tenofovir/Alafenamide Compound Drugs Manufacturer Market Share
3.5 Global Tenofovir/Alafenamide Compound Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Tenofovir/Alafenamide Compound Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tenofovir/Alafenamide Compound Drugs Market Size by Region
4.1.1 Global Tenofovir/Alafenamide Compound Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Tenofovir/Alafenamide Compound Drugs Revenue by Region (2016-2026)
4.2 North America Tenofovir/Alafenamide Compound Drugs Revenue (2016-2026)
4.3 Europe Tenofovir/Alafenamide Compound Drugs Revenue (2016-2026)
4.4 Asia-Pacific Tenofovir/Alafenamide Compound Drugs Revenue (2016-2026)
4.5 South America Tenofovir/Alafenamide Compound Drugs Revenue (2016-2026)
4.6 Middle East and Africa Tenofovir/Alafenamide Compound Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Tenofovir/Alafenamide Compound Drugs Sales in Volume by Type (2016-2026)
5.2 Global Tenofovir/Alafenamide Compound Drugs Revenue by Type (2016-2026)
5.3 Global Tenofovir/Alafenamide Compound Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Tenofovir/Alafenamide Compound Drugs Sales in Volume by Application (2016-2026)
6.2 Global Tenofovir/Alafenamide Compound Drugs Revenue by Application (2016-2026)
6.3 Global Tenofovir/Alafenamide Compound Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2026)
7.2 North America Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2026)
7.3 North America Tenofovir/Alafenamide Compound Drugs Market Size by Country
7.3.1 North America Tenofovir/Alafenamide Compound Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Tenofovir/Alafenamide Compound Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2026)
8.2 Europe Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2026)
8.3 Europe Tenofovir/Alafenamide Compound Drugs Market Size by Country
8.3.1 Europe Tenofovir/Alafenamide Compound Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Tenofovir/Alafenamide Compound Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Tenofovir/Alafenamide Compound Drugs Market Size by Region
9.3.1 Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Tenofovir/Alafenamide Compound Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2026)
10.2 South America Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2026)
10.3 South America Tenofovir/Alafenamide Compound Drugs Market Size by Country
10.3.1 South America Tenofovir/Alafenamide Compound Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Tenofovir/Alafenamide Compound Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Tenofovir/Alafenamide Compound Drugs Market Size by Country
11.3.1 Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Tenofovir/Alafenamide Compound Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Tenofovir/Alafenamide Compound Drugs Typical Distributors
12.3 Tenofovir/Alafenamide Compound Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Tenofovir/Alafenamide Compound Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Tenofovir/Alafenamide Compound Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 4. Gilead Sciences Major Business
Table 5. Gilead Sciences Tenofovir/Alafenamide Compound Drugs Product and Services
Table 6. Gilead Sciences Tenofovir/Alafenamide Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Cipla Basic Information, Manufacturing Base and Competitors
Table 8. Cipla Major Business
Table 9. Cipla Tenofovir/Alafenamide Compound Drugs Product and Services
Table 10. Cipla Tenofovir/Alafenamide Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Pharmaceuticals Major Business
Table 13. Mylan Pharmaceuticals Tenofovir/Alafenamide Compound Drugs Product and Services
Table 14. Mylan Pharmaceuticals Tenofovir/Alafenamide Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Natco Pharma Major Business
Table 17. Natco Pharma Tenofovir/Alafenamide Compound Drugs Product and Services
Table 18. Natco Pharma Tenofovir/Alafenamide Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 20. Sun Pharmaceutical Industries Major Business
Table 21. Sun Pharmaceutical Industries Tenofovir/Alafenamide Compound Drugs Product and Services
Table 22. Sun Pharmaceutical Industries Tenofovir/Alafenamide Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Beacon Pharmaceuticals Major Business
Table 25. Beacon Pharmaceuticals Tenofovir/Alafenamide Compound Drugs Product and Services
Table 26. Beacon Pharmaceuticals Tenofovir/Alafenamide Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Julphar Bangladesh Basic Information, Manufacturing Base and Competitors
Table 28. Julphar Bangladesh Major Business
Table 29. Julphar Bangladesh Tenofovir/Alafenamide Compound Drugs Product and Services
Table 30. Julphar Bangladesh Tenofovir/Alafenamide Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Tenofovir/Alafenamide Compound Drugs Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 32. Global Tenofovir/Alafenamide Compound Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Tenofovir/Alafenamide Compound Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Tenofovir/Alafenamide Compound Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 35. Head Office and Tenofovir/Alafenamide Compound Drugs Production Site of Key Manufacturer
Table 36. Global Tenofovir/Alafenamide Compound Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 37. Global Tenofovir/Alafenamide Compound Drugs Sales by Region (2021-2026) & (K Pcs)
Table 38. Global Tenofovir/Alafenamide Compound Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Tenofovir/Alafenamide Compound Drugs Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 41. Global Tenofovir/Alafenamide Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 42. Global Tenofovir/Alafenamide Compound Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Tenofovir/Alafenamide Compound Drugs Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Tenofovir/Alafenamide Compound Drugs Price by Type (2016-2021e) & (USD/Pcs)
Table 45. Global Tenofovir/Alafenamide Compound Drugs Price by Type (2021-2026) & (USD/Pcs)
Table 46. Global Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 47. Global Tenofovir/Alafenamide Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 48. Global Tenofovir/Alafenamide Compound Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Tenofovir/Alafenamide Compound Drugs Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Tenofovir/Alafenamide Compound Drugs Price by Application (2016-2021e) & (USD/Pcs)
Table 51. Global Tenofovir/Alafenamide Compound Drugs Price by Application (2021-2026) & (USD/Pcs)
Table 52. North America Tenofovir/Alafenamide Compound Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 53. North America Tenofovir/Alafenamide Compound Drugs Sales by Country (2021-2026) & (K Pcs)
Table 54. North America Tenofovir/Alafenamide Compound Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Tenofovir/Alafenamide Compound Drugs Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 57. North America Tenofovir/Alafenamide Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 58. North America Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 59. North America Tenofovir/Alafenamide Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 60. Europe Tenofovir/Alafenamide Compound Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 61. Europe Tenofovir/Alafenamide Compound Drugs Sales by Country (2021-2026) & (K Pcs)
Table 62. Europe Tenofovir/Alafenamide Compound Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Tenofovir/Alafenamide Compound Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 65. Europe Tenofovir/Alafenamide Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 66. Europe Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 67. Europe Tenofovir/Alafenamide Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 68. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 69. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales by Region (2021-2026) & (K Pcs)
Table 70. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 73. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 74. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 76. South America Tenofovir/Alafenamide Compound Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 77. South America Tenofovir/Alafenamide Compound Drugs Sales by Country (2021-2026) & (K Pcs)
Table 78. South America Tenofovir/Alafenamide Compound Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Tenofovir/Alafenamide Compound Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 81. South America Tenofovir/Alafenamide Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 82. South America Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 83. South America Tenofovir/Alafenamide Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 84. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 85. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales by Country (2021-2026) & (K Pcs)
Table 86. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 89. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 90. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Tenofovir/Alafenamide Compound Drugs Typical Distributors
Table 95. Tenofovir/Alafenamide Compound Drugs Typical Customers
List of Figures
Figure 1. Tenofovir/Alafenamide Compound Drugs Picture
Figure 2. Global Tenofovir/Alafenamide Compound Drugs Sales Market Share by Type in 2020
Figure 3. Bottled Packaging
Figure 4. Film Coated Packaging
Figure 5. Global Tenofovir/Alafenamide Compound Drugs Sales Market Share by Application in 2020
Figure 6. Chronic Hepatitis (HBV) in Adults
Figure 7. Chronic Hepatitis (HBV) in Children over 12 Years Old
Figure 8. Global Tenofovir/Alafenamide Compound Drugs Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 9. Global Tenofovir/Alafenamide Compound Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Tenofovir/Alafenamide Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Tenofovir/Alafenamide Compound Drugs Sales (2016-2026) & (K Pcs)
Figure 30. Global Tenofovir/Alafenamide Compound Drugs Production Capacity (2016-2026) & (K Pcs)
Figure 31. Global Tenofovir/Alafenamide Compound Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Tenofovir/Alafenamide Compound Drugs Market Drivers
Figure 33. Tenofovir/Alafenamide Compound Drugs Market Restraints
Figure 34. Tenofovir/Alafenamide Compound Drugs Market Trends
Figure 35. Global Tenofovir/Alafenamide Compound Drugs Sales Market Share by Manufacturer in 2020
Figure 36. Global Tenofovir/Alafenamide Compound Drugs Revenue Market Share by Manufacturer in 2020
Figure 37. Tenofovir/Alafenamide Compound Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Tenofovir/Alafenamide Compound Drugs Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Tenofovir/Alafenamide Compound Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Tenofovir/Alafenamide Compound Drugs Sales Market Share by Region (2016-2026)
Figure 41. Global Tenofovir/Alafenamide Compound Drugs Revenue Market Share by Region (2016-2026)
Figure 42. North America Tenofovir/Alafenamide Compound Drugs Revenue (2016-2026) & (USD Million)
Figure 43. Europe Tenofovir/Alafenamide Compound Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Revenue (2016-2026) & (USD Million)
Figure 45. South America Tenofovir/Alafenamide Compound Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Global Tenofovir/Alafenamide Compound Drugs Sales Market Share by Type (2016-2026)
Figure 48. Global Tenofovir/Alafenamide Compound Drugs Revenue Market Share by Type (2016-2026)
Figure 49. Global Tenofovir/Alafenamide Compound Drugs Price by Type (2016-2026) & (USD/Pcs)
Figure 50. Global Tenofovir/Alafenamide Compound Drugs Sales Market Share by Application (2016-2026)
Figure 51. Global Tenofovir/Alafenamide Compound Drugs Revenue Market Share by Application (2016-2026)
Figure 52. Global Tenofovir/Alafenamide Compound Drugs Price by Application (2016-2026) & (USD/Pcs)
Figure 53. North America Tenofovir/Alafenamide Compound Drugs Sales Market Share by Country (2016-2026)
Figure 54. North America Tenofovir/Alafenamide Compound Drugs Revenue Market Share by Country (2016-2026)
Figure 55. North America Tenofovir/Alafenamide Compound Drugs Sales Market Share by Type (2016-2026)
Figure 56. North America Tenofovir/Alafenamide Compound Drugs Sales Market Share by Application (2016-2026)
Figure 57. Europe Tenofovir/Alafenamide Compound Drugs Sales Market Share by Country (2016-2026)
Figure 58. Europe Tenofovir/Alafenamide Compound Drugs Revenue Market Share by Country (2016-2026)
Figure 59. Europe Tenofovir/Alafenamide Compound Drugs Sales Market Share by Type (2016-2026)
Figure 60. Europe Tenofovir/Alafenamide Compound Drugs Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Tenofovir/Alafenamide Compound Drugs Sales Market Share by Application (2016-2026)
Figure 65. South America Tenofovir/Alafenamide Compound Drugs Sales Market Share by Country (2016-2026)
Figure 66. South America Tenofovir/Alafenamide Compound Drugs Revenue Market Share by Country (2016-2026)
Figure 67. South America Tenofovir/Alafenamide Compound Drugs Sales Market Share by Type (2016-2026)
Figure 68. South America Tenofovir/Alafenamide Compound Drugs Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Tenofovir/Alafenamide Compound Drugs Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のテノホビル/アラフェナミド複合薬市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Tenofovir/Alafenamide Compound Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆